Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis

The aim of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS) was to assess the use of levodopa/carbidopa intestinal gel (LCIG) as monotherapy in patients with advanced Parkinson’s disease (APD) in routine clinical practice. COSMOS was an i...

Description complète

Détails bibliographiques

Auteurs principaux:	Mihaela Adriana Simu, Dragoș Cătălin Jianu, Adriana Octaviana Dulamea, Viorelia Adelina Constantin, Diana Popescu, Juan Carlos Parra, József Attila Szász
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-11-01
Collection:	Brain Sciences
Sujets:	Parkinson’s disease levodopa carbidopa intestinal gel LCIG monotherapy device aided therapies DAT
Accès en ligne:	https://www.mdpi.com/2076-3425/11/12/1566
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!